Skip to content
Govbase
Govbase
Congress·In Committee·S. 1784

Sen. Peters Introduces Bipartisan MAPS Act to Secure Drug Supply Chains and Reduce Reliance on China

MAPS Act

1 day ago·View on Congress.gov

Legislative Progress

Senate
House
President
Law

Key Points

  • The bill requires the government to create and maintain a list of essential medicines that are critical for emergency response, chronic illness treatment, and military readiness. This list must be updated at least every two years and published after each update.
  • Federal agencies must use data analytics to map pharmaceutical supply chains from raw materials through finished products and distribution, identifying vulnerabilities that threaten national security or could cause drug shortages at pharmacies.
  • The bill zeroes in on medicines that depend on foreign countries — especially China — for production. It requires a risk assessment of drugs where more than 50% of production comes from foreign entities of concern, and the Defense Department must report every six months on any drugs it buys that are sourced from or made in China.
  • The Department of Defense must file biannual reports listing all drugs it purchased that contain ingredients sourced from China or were manufactured there, creating ongoing transparency about military reliance on Chinese pharmaceutical production.
  • The bill includes strong protections for confidential business information shared between agencies during supply chain mapping, and requires robust cybersecurity measures to prevent unauthorized access to the sensitive data collected.

    From policy text

    “The Secretary shall ensure that robust cybersecurity measures are in place to prevent inappropriate access to, or unauthorized disclosure of, the information identified, exchanged, or disclosed under sections 3 and 4.”
    View in full text
HealthcareNational Security Foreign Policy

Impact Analysis

Personal Impact

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Milestones

2 milestones3 actions
Mar 19, 2026Senate

Committee on Health, Education, Labor, and Pensions. Hearings held.

May 15, 2025Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

May 15, 2025

Introduced in Senate

What Happens Next

Projected impacts based on AI analysis

180 days after enactment

Essential Medicines List published and first supply chain risk assessment completed

The public will see for the first time a comprehensive government list of which drugs are most critical and which supply chains are most vulnerable to disruption.

18 months after enactment

Full pharmaceutical supply chain mapping report submitted to Congress

Congress and the public get a detailed picture of where America's essential drugs actually come from, including which ones depend heavily on China or other foreign sources.

180 days after enactment

First DOD biannual report on China-sourced drugs delivered to Congress

Lawmakers will have hard data on how much the U.S. military depends on China for its medicines, which could drive future policy to shift production.

Related Bills

1 bill
H.R. 4191Related bill

MAPS Act

Jun 26 — Referred to the House Committee on Energy and Commerce.

Source Information

Document Type

Congressional Bill

Official Title

MAPS Act

Bill NumberS 1784
Congress119th Congress
ChamberSenate
Latest ActionCommittee on Health, Education, Labor, and Pensions. Hearings held.

Sponsor

Cosponsors

(7)
D: 2R: 4I: 1

Analysis generated by AI. Always verify with official sources.